pH-Responsive Release of Ruthenium Metallotherapeutics from Mesoporous Silica-Based Nanocarriers

Ruthenium complexes are attracting interest in cancer treatment due to their potent cytotoxic activity. However, as their high toxicity may also affect healthy tissues, efficient and selective drug delivery systems to tumour tissues are needed. Our study focuses on the construction of such drug deli...

Descripción completa

Detalles Bibliográficos
Autores principales: Mladenović, Minja, Morgan, Ibrahim, Ilić, Nebojša, Saoud, Mohamad, Pergal, Marija V., Kaluđerović, Goran N., Knežević, Nikola Ž.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8067187/
https://www.ncbi.nlm.nih.gov/pubmed/33800647
http://dx.doi.org/10.3390/pharmaceutics13040460

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8067187/
https://www.ncbi.nlm.nih.gov/pubmed/33800647
http://dx.doi.org/10.3390/pharmaceutics13040460

Ejemplares similares